Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-24 Sale | 2022-06-28 4:01 pm | Jasper Therapeutics Inc. | JSPR | Lis William Director | 49,486 | $2.0498 | $101,434 | 40,486 (Direct) | View |
| 2022-01-20 Sale | 2022-01-21 5:10 pm | Zai Lab Ltd | ZLAB | Lis William Director | 1,926 | $53.4 | $102,848 | 34,114 (Direct) | View |
| 2018-06-06 Sale | 2018-06-08 6:18 pm | PORTOLA PHARMACEUTICALS INC | PTLA | Lis William Chief Executive Officer | 5,113 | $45.21 | $231,159 | 222,035 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-10-12 Option Award | 2022-10-13 7:58 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Lis William Director | 29,500 | $0 | 69,986 (Direct) | View |
| 2022-03-21 Option Award | 2022-03-23 6:01 pm | N/A 2032-03-21 | Jasper Therapeutics Inc. | JSPR | Lis William See Remarks | 197,472 | $0 | 287,444 (Direct) | View |
| 2021-12-31 Ownership | 2022-02-14 4:05 pm | N/A N/A | Zai Lab Ltd | ZLAB | Lis William Director | 5,350 | $129.14 | 22,927 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-04 9:12 pm | N/A N/A | Zai Lab Ltd | ZLAB | Lis William Director | 7,763 | $0 | 36,040 (Direct) | View |
| 2021-09-24 Ownership | 2021-10-01 4:08 pm | N/A 2030-05-31 | Jasper Therapeutics Inc. | JSPR | Lis William Chief Executive Officer | 0 | $0 | 959,945 (Direct) | View |
| 2021-01-26 Disposition | 2021-01-28 7:06 pm | N/A 2030-05-27 | Eidos Therapeutics Inc. | EIDX | Lis William Director | 86,112 | $0 | 0 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-20 6:36 pm | N/A N/A | Zai Lab Ltd | ZLAB | Lis William Director | 3,852 | $0 | 28,277 (Direct) | View |
| 2021-01-01 Ownership | 2021-01-04 07:40 am | N/A N/A | Zai Lab Ltd | ZLAB | Lis William Director | 0 | $0 | 24,425 (Direct) | View |
| 2020-05-27 Option Award | 2020-05-29 4:05 pm | N/A 2030-05-27 | Eidos Therapeutics Inc. | EIDX | Lis William Director | 21,528 | $0 | 21,528 (Direct) | View |
| 2019-06-12 Option Award | 2019-06-13 9:23 pm | N/A 2029-06-11 | Eidos Therapeutics Inc. | EIDX | Lis William Director | 21,528 | $0 | 21,528 (Direct) | View |
| 2018-12-04 Option Award | 2018-12-07 8:42 pm | N/A 2028-12-04 | Eidos Therapeutics Inc. | EIDX | Lis William Director | 43,056 | $0 | 43,056 (Direct) | View |
| 2018-07-28 Tax Withholding | 2018-08-28 6:13 pm | N/A N/A | PORTOLA PHARMACEUTICALS INC | PTLA | Lis William Chief Executive Officer | 17,587 | $26.05 | 204,448 (Direct) | View |
| 2018-07-28 Exercise | 2018-08-28 6:13 pm | N/A N/A | PORTOLA PHARMACEUTICALS INC | PTLA | Lis William Chief Executive Officer | 35,000 | $0 | 204,448 (Direct) | View |
| 2018-05-22 Option Award | 2018-05-24 8:22 pm | N/A N/A | PORTOLA PHARMACEUTICALS INC | PTLA | Lis William Chief Executive Officer | 12,890 | $0 | 227,148 (Direct) | View |
| 2018-05-22 Tax Withholding | 2018-05-24 8:22 pm | N/A N/A | PORTOLA PHARMACEUTICALS INC | PTLA | Lis William Chief Executive Officer | 6,491 | $40.82 | 227,148 (Direct) | View |
| 2018-03-02 Tax Withholding | 2018-03-06 5:55 pm | N/A N/A | PORTOLA PHARMACEUTICALS INC | PTLA | Lis William Chief Executive Officer | 19,184 | $32.53 | 70,624 (Direct) | View |
| 2018-01-31 Option Award | 2018-02-02 8:15 pm | N/A 2028-01-30 | PORTOLA PHARMACEUTICALS INC | PTLA | Lis William Chief Executive Officer | 125,000 | $0 | 125,000 (Direct) | View |